NSRX’s Lock-Up Period Will End on February 9th (NYSEAMERICAN:NSRX)

NSRX’s (NYSEAMERICAN:NSRX) lock-up period will end on Monday, February 9th. NSRX had issued 1,250,000 shares in its public offering on August 13th. The total size of the offering was $10,000,000 based on an initial share price of $8.00. After the expiration of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

NSRX Price Performance

Shares of NSRX opened at $5.80 on Friday. NSRX has a 52-week low of $5.42 and a 52-week high of $9.99.

About NSRX

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.